SPN-812
812P412
Approved small_molecule completed
Quick answer
SPN-812 for Attention-Deficit/Hyperactivity Disorder (ADHD) is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed